MicroRNA regulation of growth factor receptor signaling in human cancer cells

Keith M Giles1, Andrew Barker, Priscilla M Zhang

  • 1Laboratory for Cancer Medicine, Centre for Medical Research, Western Australian Institute for Medical Research, University of Western Australia, Perth, WA, Australia.

Insights

MicroRNAs miR-7 and miR-331-3p directly regulate epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) respectively. This regulation impacts the Akt signaling pathway, crucial for glioblastoma and prostate cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Aberrant expression of EGFR and HER2 is common in human tumors, correlating with poor prognosis and treatment resistance.
  • The Akt signaling pathway, a downstream effector of EGFR/HER2, is vital for cancer cell proliferation, invasion, angiogenesis, and apoptosis resistance.
  • MicroRNAs (miRNAs) are key regulators of gene expression, implicated in tumor development and metastasis.

Purpose of the Study:

  • To investigate the role of specific miRNAs in regulating EGFR and HER2 expression in cancer.
  • To determine if miR-7 and miR-331-3p directly target EGFR and HER2, respectively.
  • To assess the impact of this miRNA-mediated regulation on the Akt signaling pathway in glioblastoma and prostate cancer.

Main Methods:

  • Directly validated miRNA targeting of EGFR and HER2 in glioblastoma and prostate cancer cell lines.
  • Assessed the downstream effects of miRNA-mediated EGFR/HER2 regulation on Akt signaling.
  • Detailed methodology for confirming direct miRNA-target interactions and analyzing downstream signaling.

Main Results:

  • Demonstrated that miR-7 directly targets EGFR and miR-331-3p directly targets HER2 in relevant cancer cell lines.
  • Showed that this direct regulation leads to reduced Akt activity.
  • Established a functional link between these miRNAs, their targets (EGFR/HER2), and the critical Akt pathway.

Conclusions:

  • miR-7 and miR-331-3p are direct negative regulators of EGFR and HER2, respectively.
  • These miRNAs modulate the Akt signaling pathway, offering potential therapeutic avenues for EGFR/HER2-driven cancers.
  • The findings provide a framework for validating miRNA-target interactions and their functional consequences in cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...